Human concentrative nucleoside transporter 3 transfection with ultrasound and microbubbles in nucleoside transport deficient HEK293 cells greatly increases gemcitabine uptake.
Gemcitabine is a hydrophilic clinical anticancer drug that requires nucleoside transporters to cross plasma membranes and enter cells. Pancreatic adenocarcinomas with low levels of nucleoside transporters are generally resistant to gemcitabine and are currently a clinical problem. We tested whether...
Main Authors: | Robert J Paproski, Sylvia Y M Yao, Nicole Favis, David Evans, James D Young, Carol E Cass, Roger J Zemp |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3575408?pdf=render |
Similar Items
-
Structural basis of nucleoside and nucleoside drug selectivity by concentrative nucleoside transporters
by: Zachary Lee Johnson, et al.
Published: (2014-07-01) -
Uptake of NO-releasing drugs by the P2 nucleoside transporter in trypanosomes
by: L. Soulère, et al.
Published: (1999-11-01) -
Emerging Roles of Nucleoside Transporters
by: Marçal Pastor-Anglada, et al.
Published: (2018-06-01) -
Human Equilibrative Nucleoside Transporter 1: Novel Biomarker and Prognostic Indicator for Patients with Gemcitabine-Treated Pancreatic Cancer
by: Xiao J, et al.
Published: (2024-06-01) -
Nucleobase and nucleoside transport and integration into plant metabolism
by: Christopher eGirke, et al.
Published: (2014-09-01)